4//SEC Filing
Cytosorbents Corp 4
Accession 0001144204-17-011838
$CTSOCIK 0001175151operating
Filed
Feb 27, 7:00 PM ET
Accepted
Feb 28, 5:21 PM ET
Size
5.6 KB
Accession
0001144204-17-011838
Insider Transaction Report
Form 4
BARTLETT ROBERT HAWES
Chief Medical Officer
Transactions
- Award
Stock Option (right to buy)
2017-02-24+20,000→ 20,000 totalExercise: $5.60Exp: 2017-02-24→ Common Stock (20,000 underlying)
Footnotes (1)
- [F1]Such options were granted pursuant to the CytoSorbents Corporation 2014 Long-Term Incentive Plan, and shall vest upon achievement of certain performance goals as determined in the discretion of the Board of Directors of CytoSorbents Corporation.
Documents
Issuer
Cytosorbents Corp
CIK 0001175151
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001175151
Filing Metadata
- Form type
- 4
- Filed
- Feb 27, 7:00 PM ET
- Accepted
- Feb 28, 5:21 PM ET
- Size
- 5.6 KB